Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost recent
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Moderna, melanoma and mRNA

Digest more
Top News
Overview
Highlights
 · 2d
A New mRNA Vaccine Could Prevent Skin Cancer From Returning
The companies say the vaccine prevented the return and spread of the cancer in high-risk melanoma patients.

Continue reading

 · 1d · on MSN
How Moderna's melanoma mRNA vaccine could fight deadliest skin cancer
 · 1d · on MSN
New Melanoma Vaccine Shows Promise In Fighting Cancer, Preventing Recurrence
 · 1d
Personalized Vaccine Helped Melanoma Patients Stay Cancer-Free Longer, Drugmakers Say
An experimental vaccine kept melanoma from returning or spreading in people at high risk of the skin cancer coming back, drugmakers Moderna and Merck announced Wednesday.

Continue reading

 · 1d
Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhyped
 · 1d
Moderna breakthrough brings back memories of pandemic mania
 · 1d
From Covid to Cancer: How Moderna’s Stock Jumped 177% in a Day
Moderna and the big drugmaker Merck reported that their experimental cancer vaccine extended the time before melanoma recurred in a clinical trial — the first late-stage study of its kind to succeed.

Continue reading

 · 1d
FirstFT: Moderna’s ‘landmark’ cancer treatment leads to share price surge
 · 2d
Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test
6h

Novel mRNA vaccine plus immunotherapy reduces melanoma relapse in phase 3 trial

Moderna and Merck's neoantigen treatment, combining a personalized mRNA cancer vaccine with the immunotherapy drug pembrolizumab significantly reduced the risk of melanoma recurrence in a phase 3 trial.
11h

Elon Musk Says mRNA Has ‘Tremendous’ Potential After Moderna, Merck Cancer Vaccine Breakthrough — MRNA Stock Falls Over 11% in Premarket (UPDATED)

The story has been refreshed with the latest market price action and a revised headline. Elon Musk said Wednesday that mRNA technology could fundamentally change how diseases are treated, a shift that would make medicine more of
  • Privacy
  • Terms